发明名称 |
Compositions and methods for specific regulation of pyruvate dehydrogenase kinase |
摘要 |
A peptide composition is provi'deo! which specifically inhibits the ability of δ protein kinase C (δPKC) to phosphor/late pyruvate dehydrogenase kinase (PDK) under ischemic conditions. The peptide composition is useful for treating or reducing tissue damage resulting from ischemia and/or reperfusion. |
申请公布号 |
US9217137(B2) |
申请公布日期 |
2015.12.22 |
申请号 |
US201214238449 |
申请日期 |
2012.08.10 |
申请人 |
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
发明人 |
Mochly-Rosen Daria;Qvit Nir;Dziesietnik Marie-Helene Disatnik |
分类号 |
C12N9/12 |
主分类号 |
C12N9/12 |
代理机构 |
McDermott Will & Emery LLP |
代理人 |
McDermott Will & Emery LLP |
主权项 |
1. A pharmaceutical composition comprising a δPKC-selective modulatory peptide 5 to 20 amino acids in length comprising a contiguous core sequence of 5 amino acid residues and further comprising a first cysteine residue located at the N-terminal or C-terminal end of the modulatory peptide,
wherein the contiguous core sequence is at least 60% identical to SEQ ID NO:1, and a pharmaceutically acceptable excipient. |
地址 |
Palo Alto CA US |